Hancock Whitney Corp Viatris Inc Transaction History

Hancock Whitney Corp

$5.37 Billion
Q3 2025

A detailed history of Hancock Whitney Corp transactions in Viatris Inc stock. As of the latest transaction made, Hancock Whitney Corp holds 199,513 shares of VTRS stock, worth $2.14 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

199,513

Previous 201,649 1.06%

Holding current value

$2.14 Million

Previous $1.8 Million 9.72%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 17, 2025	SELL	$8.74 - $10.69 $18,668 - $22,833	-2,136 Reduced 1.06%	199,513 $1.98 Million
Q2 2025 Aug 14, 2025	SELL	$7.26 - $9.12 $373,730 - $469,479	-51,478 Reduced 20.34%	201,649 $1.8 Million
Q1 2025 May 15, 2025	SELL	$8.68 - $12.42 $6.16 Million - $8.81 Million	-709,608 Reduced 73.71%	253,127 $2.2 Million
Q4 2024 Feb 14, 2025	SELL	$11.32 - $13.37 $55,332 - $65,352	-4,888 Reduced 0.51%	962,735 $12 Million
Q3 2024 Nov 13, 2024	BUY	$10.32 - $12.13 $23,250 - $27,328	2,253 Added 0.23%	967,623 $11.2 Million

Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $2.91 Million - $3.48 Million	289,449 Added 42.82%	965,370 $10.3 Million
Q1 2024 May 16, 2024	BUY	$11.27 - $13.53 $1.82 Million - $2.18 Million	161,243 Added 31.33%	675,921 $8.07 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $675,053 - $835,157	-76,973 Reduced 13.01%	514,678 $5.57 Million
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $941,411 - $1.11 Million	98,166 Added 19.89%	591,651 $5.83 Million
Q2 2023 Nov 13, 2023	SELL	$9.02 - $10.29 $296,090 - $337,779	-32,826 Reduced 6.24%	493,485 $4.92 Million
Q2 2023 Aug 10, 2023	SELL	$9.02 - $10.29 $296,090 - $337,779	-32,826 Reduced 6.24%	493,485 $4.93 Million
Q1 2023 Nov 13, 2023	SELL	$9.2 - $12.26 $257,802 - $343,549	-28,022 Reduced 5.06%	526,311 $5.06 Million
Q1 2023 May 16, 2023	SELL	$9.2 - $12.26 $257,802 - $343,549	-28,022 Reduced 5.06%	526,311 $5.06 Million
Q4 2022 Nov 13, 2023	BUY	$8.72 - $11.56 $530,594 - $703,402	60,848 Added 12.33%	554,333 $6.17 Million
Q4 2022 Feb 03, 2023	BUY	$8.72 - $11.56 $4.83 Million - $6.41 Million	554,333 New	554,333 $6.17 Million
Q1 2022 May 12, 2022	SELL	$9.81 - $15.4 $107,586 - $168,891	-10,967 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$12.09 - $14.68 $3,070 - $3,728	-254 Reduced 2.26%	10,967 $148,000
Q3 2021 Nov 04, 2021	SELL	$13.25 - $15.13 $14,999 - $17,127	-1,132 Reduced 9.16%	11,221 $152,000
Q2 2021 Aug 09, 2021	SELL	$12.97 - $16.15 $24,539 - $30,555	-1,892 Reduced 13.28%	12,353 $176,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $63,098 - $86,081	-4,643 Reduced 24.58%	14,245 $199,000
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $270,098 - $353,961	18,888 New	18,888 $354,000

Others Institutions Holding VTRS

# of Institutions

1,132

Shares Held

967M

Call Options Held

7.74M

Put Options Held

2.47M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account

Hancock Whitney Corp Viatris Inc Transaction History